For biopharmaceutical products the clinical programme needs to be developed on a case-by-case basis, depending on the therapeutic class and the patient population.
BioVentures Consulting Limited can advise on appropriate end-points and relevant biomarkers
BioVentures Consulting Limited can help design your clinical programme and advise on key elements such as the inclusion and interpretation of
antibody data, appropriate end-points and relevant biomarkers for the targeted therapy and clinical indication.
BioVentures Consulting Limited can also develop clinical programme and related tests for biosimilar products. For example, we can design the comparability studies, advise on the reference product, characterisation and the analytical methods involved.